Last reviewed · How we verify
NCT05069090
Effect of COVID-19 Lockdown on Alcohol and Tobacco Use in Two Chilean Universities
trial testing Lockdown and other social distancing measures in SARS-CoV-2 Infection in 1,038 participants. Completed in 30 April 2021.
30 April 2021
Quick facts
| Lead sponsor | Universidad de La Frontera |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,038 |
| Start date | 3 June 2020 |
| Primary completion | 30 April 2021 |
| Estimated completion | 30 April 2021 |
| Sites | 2 locations across Chile |
Drugs / interventions tested
- Lockdown and other social distancing measures
Conditions studied
- SARS-CoV-2 Infection — all drugs for SARS-CoV-2 Infection →
- COVID-19 — all drugs for COVID-19 →
Sponsor
Universidad de La Frontera — full company profile →
Who can join
18 and older, any sex, with SARS-CoV-2 Infection or COVID-19. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a longitudinal study of participants from two university communities in Chile. The primary objective is to examine the effect of a regional lockdown on alcohol and tobacco use, using a difference-in-difference analysis to obtain causal estimates of these COVID-19 policies.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05069090
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for SARS-CoV-2 Infection
Currently open trials in the same condition.
- NCT07079670 — Safety and Immunogenicity of NVX-CoV2705 · Phase 3 · active not recruiting
- NCT05697068 — Intervention to Prevent Household and Community Spread of COVID-19 Among Latinos · NA · active not recruiting
- NCT05172011 — Understanding the Long-term Impact of COVID on Children and Families · active not recruiting
- NCT05141058 — T Cell Therapy Opposing Novel COVID-19 Infection in Immunocompromised Patients · Phase 1 · recruiting
- NCT05046470 — SARS-CoV-2 Transmission in Belgian Primary Schools of the Federation Wallonia - Brussels: An Epidemiological Pilot Study · active not recruiting
Other Universidad de La Frontera trials
Trials by the same sponsor.
- NCT06786975 — Effectiveness and Acceptability of SDF Compared to ART for the Management of Early Childhood Caries · NA · not yet recruiting
- NCT07152197 — Effects of Resistance Exercises in Hereditary Sensory-Motor Neuropathy (Charcot-Marie-Tooth Disease) · NA · recruiting
- NCT06974071 — Effectiveness of Nonpharmacologic Therapies on Pain After Removal of Chest Drains in Postoperative Cardiac Surgery · NA · active not recruiting
- NCT06469346 — Comparison of Eccentric Exercise and Static Stretching on Muscle Flexibility · NA · active not recruiting
- NCT07156760 — Morphological Characteristics of the Upper and Lower Extremities Using Ultrasound Examination After Stroke. · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05069090 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de La Frontera
- Last refreshed: 14 October 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05069090.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing